{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:23:52Z","timestamp":1792002232701,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"PARAGONE Horizon2020","award":["R14863"],"award-info":[{"award-number":["R14863"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.vaccine.2018.01.020","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T13:17:32Z","timestamp":1516195052000},"page":"958-968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and\/or vaccinated cattle and identification of protective linear B-cell epitopes"],"prefix":"10.1016","volume":"36","author":[{"given":"Laura","family":"Garza-Cuartero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Geurden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman M.","family":"Mahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Hardham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Mulcahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.01.020_b0005","unstructured":"European Commission. Research - International Co-operation in Food, Agriculture and Biotechnology Research; 2012. http:\/\/ec.europa.eu\/research\/biosociety\/inco\/projects\/0047_en.html [accessed December 19, 2012]."},{"key":"10.1016\/j.vaccine.2018.01.020_b0010","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1128\/CMR.00012-09","article-title":"Food-borne trematodiases","volume":"22","author":"Keiser","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2018.01.020_b0015","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3201\/eid1110.050614","article-title":"Emerging foodborne trematodiasis","volume":"11","author":"Keiser","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.020_b0020","unstructured":"CDC - Centers for Disease Control and Prevention. CDC - Fasciola - Biology 2014. http:\/\/www.cdc.gov\/parasites\/fasciola\/biology.html [accessed April 2, 2014]."},{"key":"10.1016\/j.vaccine.2018.01.020_b0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13620-015-0042-5","article-title":"Determining the prevalence and seasonality of Fasciola hepatica in pasture-based dairy herds in Ireland using a Bulk Tank Milk ELISA","volume":"68","author":"Bloemhoff","year":"2015","journal-title":"Ir Vet J"},{"key":"10.1016\/j.vaccine.2018.01.020_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prevetmed.2015.05.013","article-title":"Epidemiology and impact of Fasciola hepatica exposure in high-yielding dairy herds","volume":"121","author":"Howell","year":"2015","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2018.01.020_b0035","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00436-011-2341-4","article-title":"Fasciola hepatica: time-dependent disruption of spermatogenesis following in vivo treatment with triclabendazole","volume":"109","author":"Toner","year":"2011","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2018.01.020_b0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpddr.2013.11.005","article-title":"Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle","volume":"4","author":"Brockwell","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.vaccine.2018.01.020_b0045","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.pt.2016.03.002","article-title":"Current threat of triclabendazole resistance in Fasciola hepatica","volume":"32","author":"Kelley","year":"2016","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2018.01.020_b0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-3024.2003.00619.x","article-title":"Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14","volume":"25","author":"Almeida","year":"2003","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2018.01.020_b0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.vetpar.2006.12.017","article-title":"Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD","volume":"145","author":"L\u00f3pez-Ab\u00e1n","year":"2007","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2018.01.020_b0060","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Ab\u00e1n J, Nogal-Ruiz JJ, Vicente B, Morrondo P, Diez-Ba\u00f1os P, Hillyer GV, et al. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica. 2008;153 10.1016\/j.vetpar.2008.01.023.","DOI":"10.1016\/j.vetpar.2008.01.023"},{"key":"10.1016\/j.vaccine.2018.01.020_b0065","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.145.11.3905","article-title":"Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep","volume":"145","author":"Sexton","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.01.020_b0070","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0264-410X(96)00147-8","article-title":"Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase","volume":"14","author":"Morrison","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.020_b0075","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.vaccine.2010.01.055","article-title":"Evaluation of hepatic changes and local and systemic immune responses in goats immunized with recombinant Peroxiredoxin (Prx) and challenged with Fasciola hepatica","volume":"28","author":"Mendes","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.020_b0080","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1128\/IAI.67.4.1954-1961.1999","article-title":"Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep","volume":"67","author":"Piacenza","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.01.020_b0085","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1016\/j.vaccine.2011.09.020","article-title":"The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep","volume":"29","author":"Maggioli","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.020_b0090","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.vetpar.2013.04.008","article-title":"Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development","volume":"195","author":"Dalton","year":"2013","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2018.01.020_b0095","doi-asserted-by":"crossref","unstructured":"Morphew RM, Hamilton CM, Wright HA, Dowling DJ, O\u2019Neill SM, Brophy PM. Identification of the major proteins of an immune modulating fraction from adult Fasciola hepatica released by Nonidet P40. Vet Parasitol 2013;191. 10.1016\/j.vetpar.2012.08.029.","DOI":"10.1016\/j.vetpar.2012.08.029"},{"key":"10.1016\/j.vaccine.2018.01.020_b0100","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1128\/iai.64.12.5066-5074.1996","article-title":"Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin","volume":"64","author":"Dalton","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.01.020_b0105","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0264-410X(97)00289-2","article-title":"Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica","volume":"16","author":"Mulcahy","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.020_b0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/rvsc.1998.0270","article-title":"Immune responses of cattle to experimental anti-Fasciola hepatica vaccines","volume":"67","author":"Mulcahy","year":"1999","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2018.01.020_b0115","doi-asserted-by":"crossref","first-page":"17038","DOI":"10.1074\/jbc.M308831200","article-title":"Cathepsin L1, the Major Protease Involved in Liver Fluke (Fasciola hepatica) Virulence: propeptide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells","volume":"279","author":"Collins","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2018.01.020_b0120","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.1074\/jbc.M708521200","article-title":"Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica","volume":"283","author":"Stack","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2018.01.020_b0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-3024.2001.00411.x","article-title":"Fasciola hepatica cathepsin L cysteine proteinase suppresses Bordetella pertussis-specific interferon-gamma production in vivo","volume":"23","author":"O\u2019Neill","year":"2001","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2018.01.020_b0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-3024.2000.00290.x","article-title":"Fasciola hepatica infection downregulates Th1 responses in mice","volume":"22","author":"O\u2019Neill","year":"2000","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2018.01.020_b0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1432-1033.1997.t01-1-00373.x","article-title":"Functional expression of Fasciola hepatica cathepsin L1 in Saccharomyces cerevisiae","volume":"245","author":"Roche","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2018.01.020_b0140","doi-asserted-by":"crossref","unstructured":"Cornelissen JBW, Gaasenbeek CP, Borgsteede FH, Holland WG, Harmsen MM, Boersma WJ. Early immunodiagnosis of fasciolosis in ruminants using recombinant Fasciola hepatica cathepsin L-like protease. Int J Parasitol 2001;31:728\u201337. 10.1016\/S0020-7519(01)00175-8.","DOI":"10.1016\/S0020-7519(01)00175-8"},{"key":"10.1016\/j.vaccine.2018.01.020_b0145","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1016\/j.vaccine.2010.06.039","article-title":"Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1)","volume":"28","author":"Golden","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.020_b0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcpa.2012.08.007","article-title":"Early and Late Peritoneal and hepatic changes in goats immunized with recombinant Cathepsin L1 and Infected with Fasciola hepatica","volume":"148","author":"Zafra","year":"2013","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2018.01.020_b0155","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-\u00c9cija RA, Mendes RE, Zafra R, Buffonni L, Mart\u00ednez-Moreno A, P\u00e9rez J. Pathological and parasitological protection in goats immunised with recombinant cathepsin L1 and challenged with Fasciola hepatica. 2010;185 10.1016\/j.tvjl.2009.07.004.","DOI":"10.1016\/j.tvjl.2009.07.004"},{"key":"10.1016\/j.vaccine.2018.01.020_b0160","doi-asserted-by":"crossref","unstructured":"Buffoni L, Mart\u00ednez-Moreno FJ, Zafra R, Mendes RE, P\u00e9rez-\u00c9cija A, Sekiya M, et al. Humoral immune response in goats immunised with cathepsin L1, peroxiredoxin and Sm14 antigen and experimentally challenged with Fasciola hepatica. 2012;185. 10.1016\/j.vetpar.2011.09.027.","DOI":"10.1016\/j.vetpar.2011.09.027"},{"key":"10.1016\/j.vaccine.2018.01.020_b0165","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.4049\/jimmunol.152.4.1861","article-title":"Vaccination of sheep against Fasciola hepatica with glutathione S-transferase. Identification and mapping of antibody epitopes on a three-dimensional model of the antigen","volume":"152","author":"Sexton","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.01.020_b0170","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1128\/IAI.00442-06","article-title":"Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family","volume":"74","author":"Torres","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.01.020_b0175","doi-asserted-by":"crossref","first-page":"e105323","DOI":"10.1371\/journal.pone.0105323","article-title":"In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes","volume":"9","author":"Rojas-Caraballo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.01.020_b0180","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ijpara.2003.12.011","article-title":"Identification of a novel Fasciola hepatica cathepsin L protease containing protective epitopes within the propeptide","volume":"34","author":"Harmsen","year":"2004","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2018.01.020_b0185","doi-asserted-by":"crossref","unstructured":"Villa-Mancera A, Quiroz-Romero H, Correa D, Ibarra F, Reyes-P\u00e9rez M, Reyes-Vivas H, et al. Induction of immunity in sheep to Fasciola hepatica with mimotopes of cathepsin L selected from a phage display library. Parasitology 2008;135:1437\u201345. 10.1017\/S003118200800471X.","DOI":"10.1017\/S003118200800471X"},{"key":"10.1016\/j.vaccine.2018.01.020_b0190","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tvjl.2012.03.003","article-title":"Protection and antibody isotype responses against Fasciola hepatica with specific antibody to pIII-displayed peptide mimotopes of cathepsin L1 in sheep","volume":"194","author":"Villa-Mancera","year":"2012","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2018.01.020_b0195","doi-asserted-by":"crossref","unstructured":"Villa-Mancera A, Quiroz-Romero H, Correa D, Alonso RAA. Proteolytic activity in Fasciola hepatica is reduced by the administration of cathepsin L mimotopes. J Helminthol 2011;85:51\u20135. 10.1017\/S0022149X1000026X.","DOI":"10.1017\/S0022149X1000026X"},{"key":"10.1016\/j.vaccine.2018.01.020_b0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00436-013-3650-6","article-title":"Cathepsin L1 mimotopes with adjuvant Quil A induces a Th1\/Th2 immune response and confers significant protection against Fasciola hepatica infection in goats","volume":"113","author":"Villa-Mancera","year":"2014","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2018.01.020_b0205","doi-asserted-by":"crossref","unstructured":"Cornelissen JBW, Gaasenbeek CP, Boersma W, Borgsteede FH, van Milligen FJ. Use of a pre-selected epitope of cathepsin-L1 in a highly specific peptide-based immunoassay for the diagnosis of Fasciola hepatica infections in cattle. Int J Parasitol 1999;29:685\u201396. 10.1016\/S0020-7519(99)00017-X.","DOI":"10.1016\/S0020-7519(99)00017-X"},{"key":"10.1016\/j.vaccine.2018.01.020_b0210","unstructured":"Great Britain. Ministry of Agriculture F and F. Manual of veterinary parasitological laboratory techniques. London: H.M. Stationery Office; 1986."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18300549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18300549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:24:51Z","timestamp":1759400691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18300549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0264410X18300549"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and\/or vaccinated cattle and identification of protective linear B-cell epitopes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}